Rtw Investments, LP’s Acadia Pharmaceuticals Inc Position
Does Rtw Investments, LP own Acadia Pharmaceuticals Inc (ACAD)? Yes — 7.14M shares worth $159M (+1.58% of its 13F portfolio) as of Q1 2026.
Position Value
$159M
Q1 2026
Shares
7.14M
% of Portfolio
+1.58%
Quarters Held
16
currently held
Position History ACAD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 7.14M | $159M | +1.58% |
| Q4 2025 | 7.14M | $191M | +1.91% |
| Q3 2025 | 7.14M | $152M | +1.88% |
| Q2 2025 | 9.00M | $194M | +2.76% |
| Q1 2025 | 8.54M | $142M | +2.17% |
| Q4 2024 | 8.71M | $160M | +2.42% |
| Q3 2024 | 13.71M | $211M | +3.05% |
| Q2 2024 | 13.71M | $223M | +3.45% |
| Q1 2024 | 13.83M | $256M | +3.77% |
| Q4 2023 | 11.25M | $352M | +5.50% |
| Q3 2023 | 11.58M | $241M | +5.09% |
| Q2 2023 | 9.78M | $234M | +4.46% |
| Q1 2023 | 8.24M | $155M | +3.23% |
| Q4 2022 | 3.67M | $58M | +1.19% |
| Q3 2022 | 3.67M | $60M | +1.38% |
| Q2 2022 | 4.22M | $60M | +1.54% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rtw Investments, LP’s full portfolio or all institutional holders of ACAD.